{{Rsnum
|rsid=2519093
|Chromosome=9
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABO
|Gene_s=ABO
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|position=133266456
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22672568
|Trait=None
|Title=A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
|RiskAllele=A
|Pval=8E-16
|OR=1.6900
|ORtxt=None
|OA=1
}}{{PMID Auto
|PMID=21463476
|Title=Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.
|OA=1
}}